Advertisement

Topics

Therakos, Inc. Company Profile

17:07 EST 23rd November 2017 | BioPortfolio

Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photopheresis. For more information, visit www.therakos.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Global and Asia Apheresis Equipment Market Status and Future Forecast 20132023 [Report Updated: 17102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Mallinckrodt Pharmaceuticals Medical Equipment Deals and Alliances Profile [Report Updated: 17072017] Prices from USD $250

SummaryMallinckrodt Pharmaceuticals Mallinckrodt, formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a medical device company that develops and markets photopheresis systems. The company offe...

Global and China Apheresis Equipment Market Research by Company, Type Application 20132025 [Report Updated: 20102017] Prices from USD $2000

SummaryMarket Segment as follows:By Type Membrane Apheresis Equipment Centrifugation Apheresis EquipmentBy Application Plasma Platelets RBC OthersBy Company Haemonetics Corporatio...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Uvadex [Therakos, Inc.]

UVADEX™ (Methoxsalen) STERILE SOLUTION, 20 mcg/mL

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

A transition from using multi-step procedures to a fully integrated system for performing extracorporeal photopheresis: A comparison of costs and efficiencies.

The Pitié Salpêtrière Hospital Hemobiotherapy Department, Paris, France, has been providing extracorporeal photopheresis (ECP) since November 2011, and started using the Therakos(®) CELLEX(®) ful...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease

This is a single-arm, open-label, multicenter study of the efficacy of UVADEX® (methoxsalen) Sterile Solution in conjunction with THERAKOS® CELLEX® Photopheresis Systems in pediatric pa...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex

To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).

Companies [1 Associated Companies listed on BioPortfolio]

Therakos, Inc.

Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photophe...

More Information about "Therakos, Inc." on BioPortfolio

We have published hundreds of Therakos, Inc. news stories on BioPortfolio along with dozens of Therakos, Inc. Clinical Trials and PubMed Articles about Therakos, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therakos, Inc. Companies in our database. You can also find out about relevant Therakos, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record